Bacteremia in HIV-infected children under 5 years old hospitalized in Mozambique
Bacteremia in HIV-infected children under 5 years old hospitalized in Mozambique
批准号:
9306755
负责人:
D. Troy Moon
金额:
$14.84万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-22 至 2019-06-30
关键词:
5 year oldAcquired Immunodeficiency SyndromeAcute respiratory infectionAdmission activityAdultAfricaAfrica South of the SaharaAfricanAnemiaAntibiotic susceptibilityAntibioticsBacteremiaBacteriaBacterial InfectionsBloodCase Fatality RatesCessation of lifeChildCitiesClinicalCountryDataDiarrheaDiseaseEscherichia coliEtiologyExhibitsFecesFeverFormulariesFrequenciesGastroenteritisGenomicsGeographic LocationsHIVHaemophilus influenzaeHealth systemHealthcareHigh PrevalenceHospitalsHumanIncidenceIncomeInfectionInstitutionInterventionLive BirthMalariaMalnutritionMicrobiologyMolecularMoonMozambiqueObservational StudyOrganismOutcomePathogenicityPatternPediatric HospitalsPharmaceutical PreparationsPhylogenetic AnalysisPopulationPredispositionPrevalenceProvincePublic HealthRecurrenceReportingResearchResearch InfrastructureResistanceResource AllocationResourcesRuralSalmonellaSalmonella entericaSalmonella typhimuriumSamplingSepsisSerotypingServicesStaphylococcus aureusStreptococcus pneumoniaeTestingUniversitiesUrban HealthWorkagedbaseburden of illnessgeographic differencehealth differencehealth disparitymortalitymultidisciplinarypathogenpediatric AIDSprospectivepublic health relevancerural arearural settingurban areaurban setting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Every year 4.6 million children <5 years of age (U5) die in sub-Saharan Africa. Incidence of disease for infections such as malaria, acute respiratory infection (ARI), diarrhea and human immunodeficiency virus (HIV) have been described. Existing estimates as to the incidence, mortality, or hospital burden of most pathogenic bacterial infections is predominantly limited to urban areas, thus the impact of U5 bacteremia is largely unknown as most people live in rural areas. Early studies suggest bacteremia in hospitalized African children exceeds that of high income countries and that gram-negative organisms, in particular non-typhoidal salmonella (NTS) are among the most common isolates, especially where the prevalence of HIV and malaria is high. The incidence of invasive NTS disease in Africa has been estimated at between 175-388 cases per 100,000 children aged 3-5 years. There are important differences by geographic region in U5 mortality, with the northern provinces having the highest rates respectively. Mozambique also has important urban/rural differences in health outcomes. U5 mortality in 2009 was estimated at 135/1000 live births in urban areas compared to 162/1000 live births in rural areas with higher frequency of death occurring in rural areas for each of the three main killers in children. We will conduct a prospective hospital-based observational study of HIV-infected children <5 years old, hospitalized with fever to determine the incidence, etiology, and antibiotic sensitivity patterns o culture confirmed bacteremia in representative rural and urban settings. The study will take place at Hospital Mavalane in Maputo city and the Quelimane Provincial Hospital in the Province of Zambezia, Mozambique. Our specific aims include: 1) To test the hypothesis that the incidence of bacteremia in HIV-infected children U5, hospitalized with fever is higher in children living in rural areas (Zambezia Province) compared with those living in urban areas (Maputo City); and 2) To test the hypothesis that non-typhoidal salmonella (NTS) is a major cause of bacteremia in HIV-infected children U5, hospitalized with fever in both urban Maputo City and rural Zambezia Province, Mozambique. Additionally, we will further genetically characterize NTS samples in blood and stool for the presence of the invasive ST313 strain. To accomplish these aims we have assembled a strong multidisciplinary team representing University Eduardo Mondlane (UEM) and Vanderbilt University and supported by the strong research and service infrastructures of these two major institutions. Our study holds promise to illuminate rural/urban health disparities that can then be targeted for mitigation. The results of this project will also provide crucial but currently unavailable information needed to prioritize resource allocation for microbiology capacity and guide national drug formulary practices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UEM-Partnership for Research in Implementation Science Mozambique (PRISM).
-
批准号:10755775
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2023
-
负责人:D. Troy Moon
-
依托单位:
Partnership for Research in Emerginig Viral Infections-Sierra Leone (PREVSL)
-
批准号:10613425
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2023
-
负责人:D. Troy Moon
-
依托单位:
Academic Partnership for Enhancements in Research (APER)
-
批准号:10752791
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2023
-
负责人:D. Troy Moon
-
依托单位:
Partnership for Research in Emerginig Viral Infections-Sierra Leone (PREVSL)
-
批准号:10754357
-
项目类别:
-
资助金额:$4.44万
-
财政年份:2023
-
负责人:D. Troy Moon
-
依托单位:
West Africa - Tulane University Laboratory Training Fellowship Supplement for Partnership for Research in Emerging Viral Infections Sierra Leone (PREVSL) U2RTW011248
-
批准号:10876594
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2023
-
负责人:D. Troy Moon
-
依托单位:
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
-
批准号:10259747
-
项目类别:
-
资助金额:$10.15万
-
财政年份:2020
-
负责人:D. Troy Moon
-
依托单位:
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
-
批准号:10400635
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2020
-
负责人:D. Troy Moon
-
依托单位:
UEM Partnership for Research in Implementation Science Mozambique (PRISM)
-
批准号:9301949
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2015
-
负责人:D. Troy Moon
-
依托单位:
UEM-Vanderbilt Partnership for Research in Implementation Science Mozambique (PRISM)
-
批准号:10347355
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2015
-
负责人:D. Troy Moon
-
依托单位:
海外基金